- Home
- CTRN vs BNTC Comparison
CTRN vs BNTC Comparison
Compare CTRN & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRN
- BNTC
- Stock Information
- Founded
- CTRN 1946
- BNTC 1995
- Country
- CTRN United States
- BNTC United States
- Employees
- CTRN N/A
- BNTC N/A
- Industry
- CTRN Clothing/Shoe/Accessory Stores
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- CTRN Consumer Discretionary
- BNTC Health Care
- Exchange
- CTRN Nasdaq
- BNTC Nasdaq
- Market Cap
- CTRN 280.0M
- BNTC 335.5M
- IPO Year
- CTRN 2005
- BNTC N/A
- Fundamental
- Price
- CTRN $29.09
- BNTC $10.96
- Analyst Decision
- CTRN Buy
- BNTC Strong Buy
- Analyst Count
- CTRN 2
- BNTC 5
- Target Price
- CTRN $24.50
- BNTC $26.00
- AVG Volume (30 Days)
- CTRN 55.2K
- BNTC 82.9K
- Earning Date
- CTRN 08-26-2025
- BNTC 09-25-2025
- Dividend Yield
- CTRN N/A
- BNTC N/A
- EPS Growth
- CTRN N/A
- BNTC N/A
- EPS
- CTRN N/A
- BNTC N/A
- Revenue
- CTRN $768,518,000.00
- BNTC N/A
- Revenue This Year
- CTRN $6.80
- BNTC N/A
- Revenue Next Year
- CTRN $4.61
- BNTC N/A
- P/E Ratio
- CTRN N/A
- BNTC N/A
- Revenue Growth
- CTRN 1.85
- BNTC N/A
- 52 Week Low
- CTRN $13.66
- BNTC $7.05
- 52 Week High
- CTRN $34.63
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- CTRN 41.48
- BNTC 38.01
- Support Level
- CTRN $29.07
- BNTC $10.70
- Resistance Level
- CTRN $30.73
- BNTC $11.72
- Average True Range (ATR)
- CTRN 1.06
- BNTC 0.79
- MACD
- CTRN -0.23
- BNTC -0.01
- Stochastic Oscillator
- CTRN 17.55
- BNTC 16.57
About CTRN Citi Trends Inc.
Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.